Randomized, Placebo-Controlled, Esophageal Squamous Cell Cancer Chemoprevention Trial of Selenomethionine and Celecoxib

This publication has 27 references indexed in Scilit:

• Histological precursors of oesophageal squamous cell carcinoma: results from a 13 year prospective follow up study in a high risk population
  Gut, 2005
• Failing the Public Health — Rofecoxib, Merck, and the FDA
  New England Journal of Medicine, 2004
• A Randomized Trial of Aspirin to Prevent Colorectal Adenomas
  New England Journal of Medicine, 2003
• A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer
  New England Journal of Medicine, 2003
• Trends in survival for both histologic types of esophageal cancer in U.S. surveillance, epidemiology and end results areas
  International Journal of Cancer, 2003
• Microsatellite alterations in esophageal dysplasia and squamous cell carcinoma from laser capture microdissected endoscopic biopsies
  Cancer Letters, 2003
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia
  Critical Reviews in Clinical Laboratory Sciences, 2000
• Nutrition Intervention Trials in Linxian, China: Multiple Vitamin/Mineral Supplementation, Cancer Incidence, and Disease-Specific Mortality Among Adults With Esophageal Dysplasia
  JNCI Journal of the National Cancer Institute, 1993
• Nutrition Intervention Trials in Linxian, China: Supplementation With Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General Population
  JNCI Journal of the National Cancer Institute, 1993